Table 2

Association of PVS>0% and continuous PVS to deaths and lengths of hospital and intensive care unit stay

	Outcome	Crude HR (95% CI)	P value	Adjusted HR *	P value
	Outcome	Crude HR (95% CI)	P value	(95% CI)	P value
PVS >0%	In-hospital mortality	1.46 (0.58 to 3.68)	0.43	1.15 (0.44 to 2.96)	0.78
	1-month mortality	2.04 (0.89 to 4.65)	0.09	1.77 (0.77 to 4.07)	0.18
	3-month mortality	2.61 (1.28 to 5.35)	0.008	2.29 (1.11 to 4.74)	0.03
	12-month mortality	2.20 (1.35 to 3.58)	0.001	2.00 (1.23 to 3.26)	0.006
	12-month mortality (landmark)	2.35 (1.29 to 4.28)	0.005	2.18 (1.19 to 3.99)	0.01
	Outcome	Crude regression coefficient (95% CI)	P value	*Adjusted regression coefficient (95% CI**)	P value

PVS	Days in the intensive care unit	0.02 (0.00 to 0.04)	0.01	0.02 (0.00 to 0.04)	0.04
	Days in hospital	0.14 (0.08 to 0.21)	<0.0001	0.12 (0.06 to 0.17)	<0.0001

PVS >0%	Days in the intensive care unit	0.48 (0.10 to 0.85)	0.01	0.41 (0.04 to 0.78)	0.03
	Days in hospital	2.56 (1.03 to 4.10)	0.001	1.95 (0.48 to 3.41)	0.009

*Adjusted for EuroSCORE >14 and NYHA class ≥3.
EuroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New York Heart Association; PVS, plasma volume status.